Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
Clinical trial NCT07277439 · RECRUITING
Trial details
- NCT number
- NCT07277439
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-16
- Primary completion
- 2027-02-16
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.